Colgate's (CL) Q2 results reflect continued gains in volume and pricing, offset by greater negative impacts of currency, leading to robust organic sales growth. CL raises the adjusted EPS view for 2024.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes?
Colgate-Palmolive Company (CL) beat expectations on the top and bottom lines with its second-quarter results Friday, sending its shares toward record highs.
While the top- and bottom-line numbers for Colgate-Palmolive (CL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Colgate-Palmolive (CL) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $0.77 per share a year ago.
Toothpaste maker Colgate-Palmolive raised its forecasts for annual profit and organic sales on Friday, after beating second-quarter estimates on resilient demand for its high-priced products.
The consumer products company reports second-quarter adjusted earnings of 91 cents a share, beating Wall Street estimates of 87 cents.
Colgate-Palmolive Co.'s stock CL, -0.11% rose 1.1% premarket Friday, after the consumer goods company posted better-than-expected second-quarter earnings and backed its full-year guidance. The company had net income of $1731 million, or 89 cents a share, for the quarter, up from $502 million, or 60 cents a share, in the year-earlier period.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Solid volume and pricing, and growth across categories and regions are likely to aid Colgate's (CL) Q2 results. Softness in China, high raw material costs and FX inflation are concerning.
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Colgate-Palmolive (CL) is well positioned to outperform the market, as it exhibits above-average growth in financials.